<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

World

Why are we still funding gain-of-function research?

23 March 2023

3:00 PM

23 March 2023

3:00 PM

If someone had asked you in winter 2019 your views on gain-of-function research, you would likely have given them a blank look. But since the Covid pandemic, and with the Wall Street Journal revealing in February that the US Department of Energy now thinks Covid-19 is likely to have come from the Wuhan Institute of Virology, gain-of-function research — often conducted to make viruses more infectious and more deadly — is a matter of enormous significance and should be at the forefront of a national conversation about the very real risks it poses.

Already a subscriber? Log in

Subscribe for just $2 a week

Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock this article

REGISTER


Comments

Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Close